MarketCap
Facebook
X
Telegram
Ra Medical Systems Income Statement 2025-2011 | RMED
Brief overview of financial results at Ra Medical Systems
The comparison covers a five-year financial horizon. The revenue attributed to Ra Medical Systems moved from $4.4 million to $819 thousand between the two endpoints. Overall revenue changed by −81.4%, equal to an annualized rate of about −28.6%. The negative rate indicates weakening core operations.
At the gross-profit level, the result moved from −$1.1 million to $756 thousand, a change of +170.2%. Revenue outpaced cost of revenue, allowing more sales to flow into gross profit. Gross profit as a share of revenue changed from −24.4% to 92.3%. Improving gross profitability strengthens the quality of revenue growth.
EBITDA changed from −$33.7 million to −$19 million (+43.5%). EBITDA grew faster than revenue, indicating positive operating leverage. EBITDA margin was −764.9% at the start and −2323.3% at the end. Operating return per unit of revenue declined.
The net financial result changed from −$36 million to −$17.2 million. The loss reduction is constructive, but the recovery is incomplete.
Financial takeaway
The financial trajectory is weak and requires a cautious interpretation. The financial profile benefits from a stronger gross margin and net-income growth. The overall view is constrained by limited operating profitability, weaker operating efficiency and weak sales momentum. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Ra Medical Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | - | 1.49 M | 43.4 K | 11.2 M | 31 M | 67.6 M | - | - | - | - | - | - | - |
Shares |
1.08 M | 172 K | 550 K | 1.03 M | 101 K | 1.7 M | 526 K | 369 K | - | - | - | - | - | - | - |
Historical Prices |
- | - | - | 1.44 | 0.43 | 6.88 | 36.2 | 168 | - | - | - | - | - | - | - |
Net Income |
-17.2 M | -16.6 M | -70.6 M | -26.9 M | -25.1 M | -36 M | -57 M | -30.8 M | - | - | - | - | - | - | - |
Revenue |
819 K | 420 K | 442 K | 14 K | 22 K | 4.4 M | 7.2 M | 6.26 M | - | - | - | - | - | - | - |
Cost of Revenue |
63 K | 42 K | 30 K | 161 K | 1.56 M | 5.48 M | 8.85 M | 4.21 M | 4.16 M | - | - | - | - | - | - |
Gross Profit |
756 K | 378 K | 412 K | -147 K | -1.54 M | -1.08 M | -1.65 M | 2.05 M | - | - | - | - | - | - | - |
Operating Income |
-21.1 M | -11.2 M | -78.1 M | -27 M | -29.3 M | -35.4 M | -57.7 M | -31.2 M | -17.8 M | - | - | - | - | - | - |
Interest Expense |
-2 K | -10 K | -8 K | 99 K | -14 K | 108 K | 250 K | 14 K | 4 K | - | - | - | - | - | - |
EBITDA |
-19 M | -9.13 M | -76 M | -26.5 M | -27.7 M | -33.7 M | -56 M | -30.5 M | - | - | - | - | - | - | - |
Operating Expenses |
21.9 M | 11.6 M | 78.5 M | 26.8 M | 27.7 M | 35 M | 56.1 M | 33.2 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.1 M | 11.3 M | 17.1 M | 16.2 M | 15.5 M | 26 M | 51.5 M | 30.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Ra Medical Systems
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.19 M | 1.32 M | 13.3 M | 11.3 M | 421 K | 108 K | 757 K | 743 K | 703 K | 7.01 M | 5.37 M | 5.27 M | 2.16 M | 1.09 K | 32.2 K | 20 K | 140 K | 128 | 4.09 K | 2.92 K | 3.19 K | 2.39 M | 945 K | 551 K | 3.19 M | 13.4 M | 13 M | 12.7 M | 12.7 M | 8.2 M | 8.11 M | 7.94 M | 7.89 M | 7.48 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.68 M | -2.25 M | -5.11 M | -4.04 M | - | -4.12 M | -4.22 M | -2.68 M | - | -1.93 M | -1.58 M | -66.4 M | - | -4.76 M | -8.45 M | -5.5 M | - | -4.3 M | -5.25 M | -7.24 M | - | -7.78 M | -10.1 M | -7.7 M | - | -17.4 M | -15.1 M | -14.7 M | - | -4.81 M | -8.4 M | -2.69 M | - | -1.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
432 K | 226 K | 212 K | 143 K | - | 96 K | 93 K | 82 K | - | 133 K | 96 K | 85 K | - | 14 K | 5 K | 9 K | - | 5 K | 9 K | 1.12 M | - | 914 K | 900 K | 1.37 M | - | 1.91 M | 2.15 M | 1.75 M | - | 2.06 M | 1.24 M | 969 K | - | 1.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
42 K | 18 K | 14 K | 11 K | - | 10 K | 16 K | 5 K | - | 6 K | 7 K | 10 K | - | 161 K | 66 K | 95 K | - | 246 K | 520 K | 1.37 M | - | 1.42 M | 1.17 M | 1.58 M | - | 2.42 M | 2.73 M | 1.94 M | - | 1.28 M | 990 K | 736 K | - | 693 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
390 K | 208 K | 198 K | 132 K | - | 86 K | 77 K | 77 K | - | 127 K | 89 K | 75 K | - | -147 K | -61 K | -86 K | - | -241 K | -511 K | -443 K | - | -500 K | -267 K | -210 K | - | -517 K | -580 K | -194 K | - | 784 K | 246 K | 233 K | - | 598 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-2.32 M | -3.02 M | -4.69 M | -3.58 M | - | -2.86 M | -2.72 M | -2.62 M | - | -2.73 M | -6.31 M | -66.5 M | - | -4.78 M | -8.46 M | -5.5 M | - | -7.39 M | -6.74 M | -6.87 M | - | -7.51 M | -10.1 M | -7.79 M | - | -17.6 M | -15.3 M | -15 M | - | -4.81 M | -8.39 M | -2.69 M | - | -1.72 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-5 K | -5 K | -1 K | - | - | -3 K | -1 K | -3 K | - | 803 K | 4.73 M | -84 K | - | 20 K | 12 K | -8 K | - | 16 K | 2.02 M | 52 K | - | 14 K | 15 K | 25 K | - | 72 K | 66 K | 48 K | - | 1 K | 1 K | 1 K | - | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-1.91 M | -3 M | -4.67 M | -3.04 M | - | -2.84 M | -2.7 M | -2.09 M | - | -2.72 M | -6.3 M | -65 M | - | -4.39 M | -8.14 M | -5.32 M | - | -6.14 M | -5.86 M | -6.42 M | - | -5.66 M | -8.9 M | -7.21 M | - | -17.2 M | -14.9 M | -14.7 M | - | -4.61 M | -8.29 M | -2.6 M | - | -1.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
2.71 M | 3.23 M | 4.88 M | 3.71 M | - | 2.94 M | 2.79 M | 2.69 M | - | 2.86 M | 6.4 M | 66.6 M | - | 4.78 M | 8.4 M | 5.42 M | - | 7.15 M | 6.23 M | 6.43 M | - | 7.01 M | 9.85 M | 7.58 M | - | 17.1 M | 14.8 M | 14.8 M | - | 5.59 M | 8.64 M | 2.92 M | - | 2.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.56 M | 2.95 M | 2.88 M | 3.48 M | - | 2.88 M | 2.71 M | 2.66 M | - | 2.74 M | 1.42 M | 10.2 M | - | 3.51 M | 2.48 M | 2.3 M | - | 4.21 M | 3.4 M | 3.68 M | - | 4.7 M | 7.9 M | 6.28 M | - | 15.9 M | 13.8 M | 13.2 M | - | 5.37 M | 7.62 M | 2.64 M | - | 1.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Ra Medical Systems (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
China
Israel
Britain
Canada
